Addition of danicopan to ravulizumab or eculizumab in patients with paroxysmal nocturnal haemoglobinuria and clinically significant extravascular haemolysis (ALPHA): a double-blind, randomised, phase 3 trial

Autor: Barcellini, Wilma, Barraco, Fiorenza, Beneitez Pastor, David, Capra, Marcelo, Chew, Lee Ping, Chrysavgi, Lalayanni, De Castro, Carlos, de la Tour, Régis Peffault, De Oliveira, Michel Michels, Di Bona, Eros, Forcade, Edouard, Fu, Chieh-Lin, Furha, Cossor, Gaya Valls, Anna, Giannouli, Stavroula, Gonzalez-Fernandez, Ataulfo, Griffin, Morag, Gural, Alexander, Gutierrez, Emilio Ojeda, Hernández-Rodríguez, Inés, Ibrahim, Ibrahim, Iori, Anna Paola, Ishida, Tadao, Jang, Jun Ho, Kim, Jeong-A, Kim, Jin Seok, Kitano, Toshiyuki, Kosugi, Hiroshi, Kreiniz, Natalia, Kulasekararaj, Austin, Lee, Jong Wook, Lee Lee, Lily Wong, Mayer, Jiri, Mitchell, Lindsay, Mori, Yasuo, Nishiwaki, Kaichi, Notaro, Rosario, Nunez, Ramiro, Obara, Naoshi, Oliva, Esther Natalie, Patriquin, Christopher, Pessoa, Viviani, Piatek, Caroline, Piekarska, Agnieszka, Raza, Shahzad, Risitano, Antonio Maria, Rojnuckarin, Ponlapat, Samuel, Desmond, Shammo, Jamile, Tadmor, Tamar, Takami, Akiyoshi, Tamari, Roni, Terriou, Louis, Uchiyama, Hitoji, Vannucchi, Alessandro Maria, Yamaguchi, Hiroki, Nishimura, Jun-ichi, Carrillo Infante, Cynthia, Jain, Deepak, Liu, Peng, Filippov, Gleb, Sicre de Fontbrune, Flore, Risitano, Antonio, Kulasekararaj, Austin G

Publikováno v: In The Lancet Haematology December 2023 10(12):e955-e965

Anemia en la enfermedad arterial periférica

Autor: Esteban, Carlos, Hernández-Rodríguez, Inés

Publikováno v: In Medicina Clinica 11 March 2022 158(5):221-228

Characterization of South-East Asian ovalocytosis using osmotic gradient ektacytometry

Autor: Canelo-Vilaseca, Marta, Hernández-Rodríguez, Inés, Navarro, José-Tomás

Publikováno v: In Medicina Clínica (English Edition) 12 January 2024 162(1):43-43

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Clinical characteristics and outcome of SARS-CoV-2 infection in admitted patients with chronic lymphocytic leukemia from a single European country

Autor: Muntañola, Ana, Villacampa, Guillermo, Hernández-Rivas, José Ángel, Alonso, Rosalía, Mirás, Fátima, Osorio, Santiago, Baile, Mónica, Baltasar, Patricia, López Jiménez, Javier, Hernández‑Rodríguez, Inés, Valenciano, Susana, Alfayate, Ana, Gimeno, Eva, Bárez, Abelardo, Oliveira, Ana Carla, Riaza Grau, Rosalía, Romero, Pilar, Delgado, Julio, Yáñez, Lucrecia, Zabalza, Amaya, Torres, Ana, Gómez-Roncero, María Isabel, Crespo, Marta, Córdoba, Raúl, Mateos, Juan José, Pérez, Sonia, Andreu, Rafael, Labrador, Jorge, Ruiz, María Elena, Velasquez, César Andrés, Terol, María José, Santiago, Raquel, Vidal, María Jesús, Campoy García, Fiz, Villalón, Lucía, Muiña, Begoña, Soler, Joan Alfons, Seri, Cristina, Sánchez, María José, Cuesta, Amalia, Ramos, Rafael, Sánchez‑Montalvá, Sánchez‑Montalvá, Adrán, Ruiz‑Camps, Isabel, González, Marcos, Abrisqueta, Pau, Bosch, Francesc

Publikováno v: Digital.CSIC. Repositorio Institucional del CSIC
instname
Experimental Hematology & Oncology
Experimental Hematology & Oncology, Vol 9, Iss 1, Pp 1-4 (2020)

Spain has been one the most affected countries by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative agent of coronavirus disease 2019 (COVID-19) pandemic [1, 2]. Patients with chronic lymphocytic leukemia (CLL) could be

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::90936f7ce2158a6df566d5056759b957
http://hdl.handle.net/10261/225876